Cargando…
Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes
The measurable residual disease (MRD) assessment provides an attractive predictor of allogeneic hematopoietic cell transplnat (alloHCT) outcomes. Cell-free DNA (cfDNA) has been applied to diagnosis, early detection, and disease burden monitoring in various tumors, but its utility as an MRD test in m...
Autores principales: | Pasca, Sergiu, Guo, Matthew Z., Wang, Shiyu, Stokvis, Kristin, Shedeck, Audra, Pallavajjala, Aparna, Shams, Cynthia, Pallavajjala, Roshni, DeZern, Amy E., Varadhan, Ravi, Gocke, Christopher D., Jones, Richard J., Gondek, Lukasz P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448421/ https://www.ncbi.nlm.nih.gov/pubmed/37276081 http://dx.doi.org/10.1182/bloodadvances.2023010416 |
Ejemplares similares
-
Physioxia improves the selectivity of hematopoietic stem cell expansion cultures
por: Igarashi, Kyomi J., et al.
Publicado: (2023) -
Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation
por: Godfrey, James, et al.
Publicado: (2022) -
A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation
por: Rowan, Courtney M., et al.
Publicado: (2022) -
Endothelial cell-derived angiopoietin-like protein 2 supports hematopoietic stem cell activities in bone marrow niches
por: Yu, Zhuo, et al.
Publicado: (2022) -
Machine learning–based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors
por: Xiang, Jingyu, et al.
Publicado: (2022)